Corporate Video, Sustainable Leader in Antibiotics, Statins & Antifungals, Sustainable Antibiotic Manufacturing, Centrient Sustainability Ambitions, Centrient’s Amoxicillin Production, Cephalosporin by Centrient, Global Market Leader in Nystatin, Major Penicillin G Producer Outside China, Our Purpose, Statins API Producer, The Production of Our Statins, Centrient Pharmaceuticals Acquires Astral SteriTech
Established in 1869, Centrient Pharmaceuticals is a global B2B leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. Together with tablets, capsules and finished dosage forms, it manufactures and markets intermediates and active pharmaceutical ingredients (APIs). It is a pharmaceutical company with a clear purpose ...
Established in 1869, Centrient Pharmaceuticals is a global B2B leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. Together with tablets, capsules and finished dosage forms, it manufactures and markets intermediates and active pharmaceutical ingredients (APIs). It is a pharmaceutical company with a clear purpose — to improve lives through innovative and sustainable manufacturing of medicines. Centrient is committed to ensuring quality, reliability and sustainability for its customers, partners and patients. Its vision is to be the leading, diversified and fully integrated partner for generics marketers.